Top Markets
Coin of the day
AXIM Biotechnologies, Inc. AXIM Biotechnologies, Inc.

AXIM Biotechnologies, Inc.

AXIM
Pozycja w akcjach #37613
AXIM Biotechnologies, Inc. specializes in the creation and distribution of... AXIM Biotechnologies, Inc. specializes in the creation and distribution of advanced diagnostic solutions for healthcare, focusing on critical areas such as SARS-CoV-2 (COVID-19), ocular health, and cancer treatment. The company is currently developing rapid diagnostic assays that quantify functional neutralizing antibodies, which are essential for preventing the SARS-CoV-2 virus from attaching to human cells. Additionally, it offers serological diagnostic tests designed to detect neutralizing antibodies, thereby assessing the body's adaptive immune response to the virus, and is developing tests to identify inflammation biomarkers for the effective management of COVID-19 patients. For eye health, AXIM is pioneering quick, quantitative tear tests to measure Matrix metalloproteinase-9, an inflammatory marker associated with dry eye disease. In its oncology pipeline, the firm is advancing SBI-183, an anti-metastatic compound engineered to inhibit tumor cell growth and block the spread of cancer, as well as SPX-1009, another anti-metastatic therapy aimed at determining the levels of quiescin sulfhydryl oxidase I. Established in 2010, the company was formerly known as Axim International Inc. before officially changing its name to AXIM Biotechnologies, Inc. in July 2014, and it is headquartered in San Diego, California.
Cena akcji
$0.0046
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$1.57M
Zmiana (1 dzień)
-8.00%
Zmiana (1 rok)
-9.80%
Kraj
US
Handel AXIM Biotechnologies, Inc. (AXIM)

Kategoria

Historia ceny akcji dla AXIM Biotechnologies, Inc. (AXIM)
Najwyższa cena zamknięcia: $0.00 dnia 2026-08-01

Najniższa cena zamknięcia: $10.00 dnia 2014-09-01
Historia cen akcji firmy AXIM Biotechnologies, Inc. od 2014 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -58.77%
2025 761.74%
2024 -89.76%
2023 -43.66%
2022 -89.12%
2021 -29.91%
2020 13.99%
2019 -49.55%
2018 -88.97%
2017 -12.69%
2016 1,689.26%
2015 -95.34%
2014 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE